Biocon: Biocon denosumab approved
CHMP gives favorable opinions for Biocon Biologics' denosumab biosimilars in Europe, enhancing treatment options for patients.
Read full article »
CEO
- -Biocon is an India-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes, cancer and autoimmune diseases.
Read more